bpc 157 clinical trials BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 - Research Labs

The trials yielded mixed results and provided only partial validation for a neurotrophic- based PD treatment, while underscoring multiple issues raised by this type of therapy, including toxicity, inconsistent effectiveness, and the likely need to deliver drug to both the cell body area and terminal fields

What the research on BPC-157 peptide therapy shows Here is the key point

It integrates easily into ongoing nutrient routines and offers a simple way to support daily performance and metabolic balance

Purity Peptides makes no representations, warranties, or claims regarding any application beyond legitimate research use